Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
18.92
-2.62 (-12.16%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Cidara Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
1.2823.2823.549.5712.07
Upgrade
Revenue Growth (YoY)
-94.52%-0.91%-52.60%310.81%-42.30%
Upgrade
Cost of Revenue
71.8836.7630.1773.0968.02
Upgrade
Gross Profit
-70.6-13.48-6.67-23.52-55.95
Upgrade
Selling, General & Admin
20.6213.5815.2318.7415.9
Upgrade
Operating Expenses
20.6213.5815.2318.7415.9
Upgrade
Operating Income
-91.22-27.06-21.9-42.26-71.85
Upgrade
Interest Expense
----0.21-0.26
Upgrade
Interest & Investment Income
5.8120.19--
Upgrade
EBT Excluding Unusual Items
-85.41-25.07-21.71-42.47-72.11
Upgrade
Pretax Income
-170.29-25.07-21.71-42.47-72.11
Upgrade
Income Tax Expense
-0.020.01--
Upgrade
Earnings From Continuing Operations
-170.29-25.08-21.72-42.47-72.11
Upgrade
Earnings From Discontinued Operations
0.462.15-11.86--
Upgrade
Net Income
-169.83-22.93-33.58-42.47-72.11
Upgrade
Preferred Dividends & Other Adjustments
----2.76
Upgrade
Net Income to Common
-169.83-22.93-33.58-42.47-74.87
Upgrade
Shares Outstanding (Basic)
64332
Upgrade
Shares Outstanding (Diluted)
64332
Upgrade
Shares Change (YoY)
45.26%25.15%33.18%26.22%38.83%
Upgrade
EPS (Basic)
-26.75-5.25-9.61-16.19-36.03
Upgrade
EPS (Diluted)
-26.75-5.25-9.61-16.20-36.03
Upgrade
Free Cash Flow
-176.66-22.94-28.59-25.27-54.6
Upgrade
Free Cash Flow Per Share
-27.82-5.25-8.19-9.64-26.27
Upgrade
Gross Margin
--57.90%-28.40%-47.44%-
Upgrade
Operating Margin
-7154.43%-116.22%-93.20%-85.24%-595.42%
Upgrade
Profit Margin
-13319.77%-98.49%-142.94%-85.67%-620.48%
Upgrade
Free Cash Flow Margin
-13855.84%-98.51%-121.69%-50.98%-452.45%
Upgrade
EBITDA
-91.07-26.95-21.76-42.07-71.56
Upgrade
EBITDA Margin
--115.74%-92.59%-84.86%-
Upgrade
D&A For EBITDA
0.150.110.140.190.29
Upgrade
EBIT
-91.22-27.06-21.9-42.26-71.85
Upgrade
EBIT Margin
--116.22%-93.20%-85.24%-
Upgrade
Revenue as Reported
1.2823.2823.549.5712.07
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q